Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease.

Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP; Scleroderma Lung Study Research Group.

Chest. 2008 Aug;134(2):358-67. doi: 10.1378/chest.07-2444. Epub 2008 Jul 18.

PMID:
18641099
[PubMed - indexed for MEDLINE]
2.

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.

Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin DP.

Chest. 2009 Nov;136(5):1333-40. doi: 10.1378/chest.09-0108.

PMID:
19892673
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.

Patiwetwitoon S, Wangkaew S, Euathrongchit J, Kasitanon N, Louthrenoo W.

J Clin Rheumatol. 2012 Aug;18(5):229-33. doi: 10.1097/RHU.0b013e318261176f.

PMID:
22832288
[PubMed - indexed for MEDLINE]
4.

Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study.

Theodore AC, Tseng CH, Li N, Elashoff RM, Tashkin DP.

Chest. 2012 Sep;142(3):614-21.

PMID:
22156609
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis.

Ostojić P, Damjanov N.

Clin Rheumatol. 2006 Jul;25(4):453-7. Epub 2006 Apr 28.

PMID:
16261285
[PubMed - indexed for MEDLINE]
6.

[Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].

Salaffi F, Carotti M, Baldelli S, Bichi Secchi E, Manganelli P, Subiaco S, Salvolini L.

Radiol Med. 1999 Jan-Feb;97(1-2):33-41. Italian.

PMID:
10319097
[PubMed - indexed for MEDLINE]
7.

Interstitial lung disease in systemic sclerosis.

Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, Chan S, Tse HF, Wong RW, Lam WK, Lau CS.

Acta Radiol. 2003 May;44(3):258-64.

PMID:
12751995
[PubMed - indexed for MEDLINE]
8.

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.

Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP; Scleroderma Lung Study Research Group.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):91-8. Epub 2007 Sep 27.

PMID:
17901414
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation.

Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M.

Chest. 2003 Apr;123(4):1096-103.

PMID:
12684299
[PubMed - indexed for MEDLINE]
10.

HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.

Bellia M, Cannizzaro F, Scichilone N, Riili M, Triolo G, Midiri M, Lagalla R.

Radiol Med. 2009 Mar;114(2):190-203. doi: 10.1007/s11547-009-0367-9. Epub 2009 Mar 5. English, Italian.

PMID:
19266260
[PubMed - indexed for MEDLINE]
11.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.

Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.

PMID:
22169458
[PubMed - indexed for MEDLINE]
12.

[Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods help predict further progression of disease?].

Fasano L, Zompatori M, Monetti N, Battista G, Pacilli AM, Scioscio V Di, Sciascia N.

Radiol Med. 1999 Oct;98(4):268-74. Italian.

PMID:
10615366
[PubMed - indexed for MEDLINE]
13.

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr.

Arthritis Rheum. 2007 Aug;56(8):2740-6.

PMID:
17665460
[PubMed - indexed for MEDLINE]
Free Article
14.

Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.

Furuya Y, Kuwana M.

J Rheumatol. 2011 Oct;38(10):2186-92. doi: 10.3899/jrheum.110499. Epub 2011 Sep 1.

PMID:
21885489
[PubMed - indexed for MEDLINE]
15.

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma.

Davas EM, Peppas C, Maragou M, Alvanou E, Hondros D, Dantis PC.

Clin Rheumatol. 1999;18(6):455-61.

PMID:
10638770
[PubMed - indexed for MEDLINE]
16.

High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia.

Lee HY, Seo JB, Steele MP, Schwarz MI, Brown KK, Loyd JE, Talbert JL, Schwartz DA, Lynch DA.

Chest. 2012 Dec;142(6):1577-83. doi: 10.1378/chest.11-2812.

PMID:
23364926
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study.

Panopoulos ST, Bournia VK, Trakada G, Giavri I, Kostopoulos C, Sfikakis PP.

Lung. 2013 Oct;191(5):483-9. doi: 10.1007/s00408-013-9499-8. Epub 2013 Aug 8.

PMID:
23925736
[PubMed - indexed for MEDLINE]
18.

Pulmonary survival study in 91 patients with systemic sclerosis.

Poormoghim H, Lakeh MM, Mohammadipour M, Talehy-Moineddin S, Sodagari F.

Rheumatol Int. 2011 Dec;31(12):1577-82. doi: 10.1007/s00296-010-1501-7. Epub 2010 May 23.

PMID:
20496069
[PubMed - indexed for MEDLINE]
19.

Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.

Volpinari S, La Corte R, Bighi S, Ravenna F, Prandini N, Lo Monaco A, Trotta F.

Rheumatol Int. 2011 Sep;31(9):1183-8. doi: 10.1007/s00296-010-1390-9. Epub 2010 Mar 30.

PMID:
20352228
[PubMed - indexed for MEDLINE]
20.

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.

Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P.

Int J Rheum Dis. 2009 Sep;12(3):239-42. doi: 10.1111/j.1756-185X.2009.01417.x.

PMID:
20374353
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk